Patients with a foveal bulge had significantly enhanced visual acuity if they also had resolved diabetic macular edema (DME) ...

About AXPAXLI AXPAXLI™ (axitinib intravitreal injection, also known as OTX-TKI) is an investigational, bioresorbable, hydrogel incorporating axitinib, a small molecule, multi-target, tyrosine kinase ...

311 subjects enrolled across various stages of loading and randomization in SOL-R, Ocular's second registrational trial of AXPAXLI in wet AMD, as of January 10, 2024 First wet AMD registrational trial ...

Across all DME patients dosed to date, 4D-150 continues to be well tolerated with no intraocular inflammation observed at any timepoint or dose ...

1 School of Intelligence Engineering, Shandong Management University, Jinan, China 2 Department of Ophthalmology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, ...

Valo Health’s Rho kinase (ROCK) 1 and 2 inhibitor has failed to reduce the severity of diabetic retinopathy in a phase 2 trial, leading the Flagship-founded biotech to drop the candidate.

Diabetic macular edema can result in low vision or vision loss. Early treatment can help preserve vision longer. Diabetic macular edema (DME) is a complication of diabetes. Over time, high blood ...

Intraocular Steroid Injection: Administration of steroids straight into the eye helps minimize swelling and scar tissue development in the eyes of patients suffering from diabetic retinopathy. This ...

The vision formation in humans is due to human eyes. Human eye has three main layers i.e. the sclera, choroid and the retina. Retina is the innermost layer of an eye where the scaled and inverted ...

OCT is useful in diagnosing and monitoring macular edema and epiretinal membrane ... acute zonal occult outer retinopathy, multifocal choroiditis and Vogt–Koyanagi–Harada disease.